Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)

Meagan A. Jacoby, Laura Finn, Ashkan Emadi, Nakhle S. Saba, Bayard L. Powell, Karen Seiter, Rosella Garcia, Stefan Faderl, Heather J. Male

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2539-2542
Number of pages4
JournalLeukemia and Lymphoma
Issue number10
StatePublished - 2021

Cite this